Pharmacokinetic Study of Tenofovir Disoproxil Fumarate Combined with Rifampin in Healthy Volunteers

Tenofovir disoproxil fumarate (tenofovir DF) was studied in combination with rifampin in 24 healthy subjects in a multiple-dose, open-label, single-group, two-period study. All subjects were given tenofovir DF at 300 mg once a day (QD) from days 1 to 10 (period 1). From days 11 to 20 the subjects re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Droste, J. A. H., Verweij-van Wissen, C. P. W. G. M., Kearney, B. P., Buffels, R., vanHorssen, P. J., Hekster, Y. A., Burger, D. M.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology (ASM) 2005
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC547290/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15673751/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.49.2.680-684.2005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares